EL FENOMENO DE LAS DROGAS EN EUROPA: NUEVOS RETOS EN EUROPA - Alexis Goosdeel, EMCDDA - Plan Nacional ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
EL FENOMENO DE LAS DROGAS EN EUROPA: NUEVOS RETOS EN EUROPA Alexis Goosdeel, EMCDDA Delegación del Gobierno para el Plan Nacional Sobre Drogas Madrid, 9 de Febrero de 2019
¿DONDE ESTAMOS?
2
Drug trends: 20 years of change
Decline Heroin use, injection and HIV drug-related infections
Levels of drug use below the prevalence rates observed two decades ago
Nationally differentiated stimulants markets develop & stimulants become more
important
Polydrug use and consumers more permissive in their drug choices…diffusion and
new developments occur more rapidly
The emergence of NPS and the difficulties associated with measuring the ‘use’
3
The success of Europe’s response to the heroin
epidemics and new challenges
Historical lows for new HIV incidence among
20 years of scaling up of OST PWID at record lows
opioid treatment demands
54 000 EU28
628 000
EU15
27 000
73 400
2006 2008 2010 2012 2014 2016
1993 2008 2016
HCV and age: a ticking time
AGEING OPIOID POPULATION DRD highest among the oldest
AGE DISTRIBUTION OF TREATMENT ENTRANTS bomb
PREVALENCE (%) – MEDIAN AND RANGE
AT THE SAME TIME… • Lability relationship to substances • A market of 24-30 Billions €/year • Mass market v/s Niche market • Amplified global dynamics, faster impact at local level (« Glocal ») • Poly-drug use + blurred boundaries • Vanishing of the perception of norms
CITIUS, ALTIUS, FORTIUS*
• IMPROVEMENT PERFORMANCE
• CHEMSEX
• MICRO-DOSING LSD
• INCREASED POTENCY
• ABUSE PRESCRIPTION DRUGS
• FAKE MEDICINES
• MDMA
• MONITORING, EPIDEMIOLOGY, EVENTS-
BASED, OSI
© iStockPhoto *« FASTER, HIGHER, STRONGER » 6
THE RISE OF NPS
• BENZODIAZEPINES (real and fake)
• SPICE – CANNABINOIDS
• CATHINONES
• OPIOIDS
• FENTANYLS
Prince Avril 2016
USA 72.000 deaths 2017
7
Photo by Hans Vivek on Unsplash
NEW ADDICTIVE BEHAVIOURS
Photo by Carl Raw on Unsplash
8
NEW TECHS, NEW CHALLENGES
9
Cannabis: a more complex set of policy
challenges?
• 88 Million Adults (LTP)
• Increases in new
treatments
• Innovation in forms,
products & delivery
systems
• Global developments
• Cross over with other
policy areas (e.g. drugs
and driving)WHAT DO WE DO?
EMCDDA STRATEGY 2025
13MONITORING WITH A PURPOSE
14VISION
A healthier and more secure
Europe through better informed
drug policy and actionSTRATEGIC OBJECTIVES FOR HEALTH
UNDERSTAND EVOLUTION OF DRUG USE
IDENTIFY & RESPOND RAPIDLY TO NEW
HEALTH THREATS
REDUCE DRUG-RELATED FATALITIES AND
MORBIDITY
SUPPORT POLICIES ADDRESSING HEALTH
AND SOCIAL CONSEQUENCES OF DRUG USESTRATEGIC OBJECTIVES FOR SECURITY
UNDERSTAND THE SIZE AND DYNAMICS OF
DRUG MARKETS
IDENTIFY & RESPOND RAPIDLY TO NEW
SECURITY THREATS
IMPROVE UNDERSTANDING OF THE
CONSEQUENCES OF DRUG-RELATED
CRIME
SUPPORT POLICY AND OPERATIONAL
RESPONSES TO DRUG-RELATED SECURITY
ISSUES¿QUE NOS ESTA ESPERANDO?
18THREATS OR OPPORTUNITIES?
19CHALLENGES TO DEMOCRACY
20BREXIT
2122
EU BUDGET 2021-2027
23EMCDDA REGULATION
24NEW SOURCES OF INFORMATION
25NEW FORMS OF KNOWLEDGE
26WASTE WATER EPIDEMIOLOGY
Photo by HelpStay.com on Unsplash 27WORLD IS CHANGING
28CHANGE IS LIFE
« Donde una
puerta se
cierra, otra se
abre »
Miguel de Cervantes, Don Quijote, Capítulo XXI
29A NEW MODEL
30« WE CANNOT SOLVE OUR PROBLEMS WITH THE
SAME THINKING WE USED WHEN WE CREATED
THEM »
ALBERT EINSTEIN
REINTRODUCING ALTERITY…
Photo by Brunel Johnson on Unsplash
31Lisbon Addictions 2019: The future of addictions
New frontiers for policy, practice and science
• Tracks
• Futures: identifying and meeting
emerging needs: prediction,
preparedness, innovations and new
challenges;
• Better practice: improving how we
• Keydates respond; supporting the
development and implementation of
23.10.2018: Registration & call for abstracts more effective prevention, treatment,
and harm reduction interventions;
31.01.2019: Deadline for abstracts • Better science: aetiology, basic
science, neuroscience and pre-clinical
31.05.2019: Notification to authors studies;
29.06.2019: Deadline late-breaking abstracts • Better methods: epidemiology,
monitoring estimates and models;
23–25.10.2019: Conference • Better society: overcoming barriers,
effective policies, regulations and
laws; culture and context
• Call for abstracts
• Oral presentations | Short
communications | Posters
• Structured sessions | Workshops
www.lisbonaddictions.eu — #LxAddictions19 32You can also read
